Skip to main content

Research portfolio

Our portfolio spans a range of methodologies and types of research. Some of our studies are highlighted below.

StudyTitleOur roleStatus
MENACA randomised, open-label trial of a Multimodal Intervention (Exercise, Nutrition and Anti-inflammatory Medication) plus standard care versus standard care alone to prevent/attenuate Cachexia in advanced cancer patients undergoing chemotherapy.Co-investigator: Anthony ByrneIn setup
EMPOWEREvaluating a patient designed tool to reduce harm from cancer associated thrombosisChief-Investigator: Simon NobleIn setup
HIDDEN Hospice in-patient deep vein thrombosis detection studyCo-investigator: Simon Noble; Annmarie NelsonOpen
Optcare NeuroEvaluation of the clinical and cost-effectiveness of Short-term Integrated Palliative Care Services (SIPC) to OPTimise CARE for people with advanced longterm Neurological conditionsCo-investigator: Anthony ByrneOpen
ROCSPalliative radiotherapy in addition to self expanding metal stent for improving outcomes of dysphagia and survival in advanced oesophageal cancer

Chief-Investigator: Anthony Byrne. Co-Investigator: Annmarie Nelson

CARIADCaring for the dying at home: can lay carers safely give extra, as-needed, symptom control to their loved ones using injections under the skin?Co-investigator: Anthony Byrne, Annmarie NelsonOpen
Bereavement Core Outcomes Supporting people bereaved through advanced illness: a systematic review of the evidence and development of a core outcome set for bereavement research in palliative careChief-Investigator: Emily HarropOpen
PACTDevelopment of an intervention to support lung cancer Patients and their clinicians when considering systemic Anti-Cancer Therapy. Chief-Investigator: Annmarie NelsonReporting stage
EAGLEImproving the wellbeing of men by addressing the late effects of radical treatment for prostate cancerChief-Investigator: John Stafforth; Annmarie NelsonReporting stage